Back to companies

DAEWOONG PHARMA

069620KRKRX

대웅제약

Revenue
₩1.4tn
FY2024
Operating income
₩147.9bn
FY2024
Employees
—
Founded
—

Source: Korea Financial Supervisory Service DART (Open DART API)